$0.18 +0.01 (5.75%) Rexahn Pharmaceuticals Inc - NYSE Amex Equities

Jan. 20, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 0.18
Trade Time: Jan 20 04:00 PM Eastern Daylight Time
Change: +0.01 (5.75%)
Prev Close: 0.17
Open: 0.19
Bid: 0.18
Ask: 0.19
  1. No results found.
  1. Rexahn Pharmaceuticals Presents an Update of the Ongoing Phase IIa Clinical Trial of RX-3117 in Metastatic Pancreatic Cancer at the American Society of Clinical Oncology (ASCO) 2017 Gastrointestinal Cancers Symposium

    GlobeNewswire | Jan. 20, 2017 | 09:00AM EST
  2. Rexahn Pharmaceuticals' Archexin® Shows Dose-Dependent Tumor Reduction in a Phase IIa Clinical Study

    Benzinga | Jan. 11, 2016 | 09:06AM EST
  3. Rexahn Pharmaceuticals Reports Interim Clinical Data for Archexin(R) at the 14th International Kidney Cancer Symposium

    Benzinga | Nov. 5, 2015 | 09:02AM EST
  4. Rexahn Pharmaceuticals Presents Preliminary Clinical Data for Supinoxin(TM) and RX-3117 Oncology Programs at the European Cancer Congress 2015

    Benzinga | Sep. 28, 2015 | 08:02AM EST
  5. Rexahn Pharmaceuticals Awarded Patent in Japan for Novel Targeted Cancer Drug Delivery Platform

    Benzinga | Jul. 14, 2015 | 08:04AM EST
  6. Rexahn Pharmaceuticals to Present Data on RX-3117 & Supinoxin at the 2015 American Association for Cancer Research Annual Meeting

    Benzinga | Apr. 20, 2015 | 08:03AM EST
  7. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  8. Rexahn Receives A Notice of Allowance From The U.S. Patent And Trademark Office For A Novel Targeted Cancer Drug Delivery Platform

    Benzinga | Sep. 3, 2014 | 08:08AM EST
  9. Rexahn Presents Data from Preclinical Studies of RX-21102

    Benzinga | Apr. 21, 2014 | 08:00AM EST
  10. Rexahn Pharmaceuticals to Present Data at American Association for Clinical Research Annual Meeting

    Benzinga | Apr. 2, 2014 | 08:00AM EST
  11. Mid Morning Gainers for March 11th, 2014

    Benzinga | Mar. 11, 2014 | 10:20AM EST
  12. Morning Movers for Feb. 26, 2014: ANIK, JAKK, ZAGG, PLUG, TASR, ANF Moving Higher, FST, UTIW, SEAC, FSLR, DWA Lower

    Benzinga | Feb. 26, 2014 | 09:40AM EST
  13. Morning Market Losers

    Benzinga | Jan. 14, 2014 | 10:02AM EST
  14. Morning Market Movers

    Benzinga | Jan. 13, 2014 | 09:54AM EST
  15. Rexahn Pharmaceuticals Initiates Dosing in Phase I Trial of SupinoxinTM (RX-5902) a Candidate for Treating Solid Cancer Tumors

    Benzinga | Aug. 7, 2013 | 07:01AM EST
Trading Center